In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
 Chayakrit Krittanawong
Chayakrit Krittanawong
Chayakrit Krittanawong Chayakrit Krittanawong

Baylor College of Medicine, Houston (United States of America)

Speciality : Acute Coronary Syndromes

Dr. Chayakrit Krittanawong is a clinician-scientist interested in precision medicine, using the integrative omics and emerging technologies such as artificial intelligence or blockchain to assist physicians and patients worldwide. He has been involved with numerous investigational studies in cardiovascular medicine as a principal investigator. He has been the primary author of publications in Circulation, Journal of the American College of Cardiology (JACC), European Heart Journal, JAMA Cardiology, Nature Review Cardiology, JACC Imaging, Heart, and BMJ innovation. He serves as a reviewer for multiple journals, including The Lancet, Nature Genetics, Annals of Internal Medicine, Circulation, JACC, JAMA Cardiology, Journal of the American Heart Association (JAHA), Lancet Digital Health, JACC Imaging, JACC Cardiovascular Interventions and Journal of Graduate Medical Education (JGME). Dr. Krittanawong serves on the ACC Guidelines and Documents Task Forces on the Solution Set.

1 presentation from this speaker

Normal ranges of right atrial strain: a systematic review and meta-analysis

Event : ESC Congress 2016

  • Session : Echo-Doppler - Other
  • Speaker : C Krittanawong (New York,US)

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are